The Organoid Platform: Promises and Challenges as Tools in the Fight against COVID-19
Article 2021 en
Authors
MG
Maarten H. Geurts
JV
Jelte van der Vaart
JB
Joep Beumer
Abstract
1 min read
Many pathogenic viruses that affect man display species specificity, limiting the use of animal models. Studying viral biology and identifying potential treatments therefore benefits from the development of in vitro cell systems that closely mimic human physiology. In the current COVID-19 pandemic, rapid scientific insights are of the utmost importance to limit its impact on public health and society. Organoids are emerging as versatile tools to progress the understanding of SARS-CoV-2 biology and to aid in the quest for novel treatments.
Luke S. Hillary, Kata Farkas, Kathryn H. Maher, Anita O. Lucaci, Jamie Thorpe, Marco A. Distaso, William H. Gaze, Steve Paterson, Terry Burke, Thomas R. Connor, James E. McDonald, Shelagh K. Malham, Davey L Jones
Mart M. Lamers, Tim I. Breugem, Anna Z. Mykytyn, Yiquan Wang, Nathalie Gröen, Kèvin Knoops, Debby Schipper, Jelte van der Vaart, Charlotte D. Koopman, Jingshu Zhang, Douglas C. Wu, Petra B. van den Doel, Theo M. Bestebroer, Corine H. GeurtsvanKessel, Peter J. Peters, Mauro J. Muraro, Hans Clevers, Nicholas C. Wu, Bart L. Haagmans
Discussion(0)
No comments yet. Be the first to comment.